Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8JT6

5-HT1A-Gi in complex with compound (R)-IHCH-7179

Summary for 8JT6
Entry DOI10.2210/pdb8jt6/pdb
EMDB information36634
DescriptorGuanine nucleotide-binding protein G(i) subunit alpha-1, Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1, ScFv16, ... (9 entities in total)
Functional Keywordsserotonin receptor, 5-ht1ar, gi-protein, membrane protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains5
Total formula weight178793.33
Authors
Chen, Z.,Xu, P.,Huang, S.,Xu, H.E.,Wang, S. (deposition date: 2023-06-21, release date: 2024-02-28, Last modification date: 2024-11-20)
Primary citationChen, Z.,Yu, J.,Wang, H.,Xu, P.,Fan, L.,Sun, F.,Huang, S.,Zhang, P.,Huang, H.,Gu, S.,Zhang, B.,Zhou, Y.,Wan, X.,Pei, G.,Xu, H.E.,Cheng, J.,Wang, S.
Flexible scaffold-based cheminformatics approach for polypharmacological drug design.
Cell, 187:2194-2208.e22, 2024
Cited by
PubMed Abstract: Effective treatments for complex central nervous system (CNS) disorders require drugs with polypharmacology and multifunctionality, yet designing such drugs remains a challenge. Here, we present a flexible scaffold-based cheminformatics approach (FSCA) for the rational design of polypharmacological drugs. FSCA involves fitting a flexible scaffold to different receptors using different binding poses, as exemplified by IHCH-7179, which adopted a "bending-down" binding pose at 5-HTR to act as an antagonist and a "stretching-up" binding pose at 5-HTR to function as an agonist. IHCH-7179 demonstrated promising results in alleviating cognitive deficits and psychoactive symptoms in mice by blocking 5-HTR for psychoactive symptoms and activating 5-HTR to alleviate cognitive deficits. By analyzing aminergic receptor structures, we identified two featured motifs, the "agonist filter" and "conformation shaper," which determine ligand binding pose and predict activity at aminergic receptors. With these motifs, FSCA can be applied to the design of polypharmacological ligands at other receptors.
PubMed: 38552625
DOI: 10.1016/j.cell.2024.02.034
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

248335

PDB entries from 2026-01-28

PDB statisticsPDBj update infoContact PDBjnumon